GlassScriptPhysician profile
Bushra Khan
NPI 1861747289
$12,584.90
in general payments reported to CMS, 2019-2025
53 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,661 · 2020: $1,773 · 2021: $2,808 · 2022: $2,758 · 2023: $1,100 · 2024: $828 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,584.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,822.17 | 2019-2025 | |
| Biogen, INC. | $1,147.55 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Novartis Pharmaceuticals Corporation | $1,034.64 | 2019-2025 | |
| Ucb, INC. | $770.78 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Supernus Pharmaceuticals, INC. | $733.06 | 2019-2022 | |
| Sk Life Science, INC. | $599.26 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $507.33 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $449.76 | 2019-2025 | Rytary, Crexont, Lyvispah |
| Csl Behring | $419.00 | 2019-2023 | Hizentra |
| Biohaven Pharmaceutical Holding Company LTD. | $408.93 | 2022 | |
| Emd Serono, INC. | $388.73 | 2020-2025 | Mavenclad, Mavenclad |
| Alexion Pharmaceuticals, INC. | $276.23 | 2019-2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $258.70 | 2019-2025 | Ongentys, Ingrezza |
| Biohaven Pharmaceuticals, INC. | $222.20 | 2020-2021 | |
| Pfizer INC. | $212.51 | 2019-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $212.50 | 2019-2022 | |
| Eisai INC. | $197.88 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $196.52 | 2020-2022 | |
| Boston Scientific Corporation | $195.10 | 2024-2025 | General - Dbs, Vercise, Watchman Flx |
| Amgen INC. | $194.61 | 2019-2025 | Uplizna |
| Lilly USA, LLC | $188.17 | 2019-2022 | |
| Celgene Corporation | $179.04 | 2020-2023 | Zeposia |
| Genzyme Corporation | $176.87 | 2019-2021 | |
| Lundbeck LLC | $159.99 | 2020-2025 | Vyepti, Rexulti |
| Mallinckrodt Hospital Products INC. | $148.02 | 2020-2024 | Acthar |
| Genentech USA, INC. | $145.60 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Otsuka America Pharmaceutical, INC. | $123.28 | 2023-2024 | Rexulti, Nuedexta |
| Sumitomo Pharma America, INC. | $108.18 | 2023-2024 | Aptiom |
| Neurelis, INC. | $107.33 | 2021-2023 | Valtoco |
| Livanova USA, INC. | $106.87 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Astrazeneca Pharmaceuticals LP | $93.85 | 2019 | |
| Acorda Therapeutics, INC | $85.29 | 2019-2023 | Inbrija |
| E.R. Squibb & Sons, L.L.C. | $65.29 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $60.62 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $59.27 | 2021-2022 | |
| Grifols USA, LLC | $57.97 | 2020-2025 | Gamunex-C |
| Acadia Pharmaceuticals INC | $52.12 | 2023-2024 | Nuplazid |
| Collegium Pharmaceutical, INC. | $50.73 | 2022 | |
| Abbott Laboratories | $41.52 | 2025 | Infinity |
| Exact Sciences Corporation | $41.47 | 2025 | Cologuard Collection Kit |
| Upsher-Smith Laboratories LLC | $37.91 | 2020 | |
| Argenx US, INC. | $34.19 | 2025 | Vyvgart Hytrulo |
| Promius Pharma LLC | $30.93 | 2019 | |
| Ossur Americas, INC. | $26.59 | 2025 | |
| Life Molecular Imaging LTD | $21.25 | 2025 | Neuraceq |
| Nalu Medical, INC. | $19.10 | 2025 | Nalu Neurostimulation System |
| Sandoz INC. | $19.08 | 2024 | |
| Avanir Pharmaceuticals, INC. | $18.68 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.81 | 2019 | |
| Viiv Healthcare Company | $16.86 | 2025 | Dovato |
| Irhythm Technologies, INC. | $15.81 | 2024 | Zio Xt Patch, Zio Monitor |
| Aucta Pharmaceuticals, INC. | $14.35 | 2024 | Motpoly Xr |
| Medtronic, INC. | $13.40 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bushra Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.